Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
By Prakhar Srivastava and Pritam Biswas (Reuters) -Metsera, which is developing weight-loss drugs, said on...
By Prakhar Srivastava and Pritam Biswas (Reuters) -Metsera, which is developing weight-loss drugs, said on...
By Aditya Soni and Zaheer Kachwala (Reuters) – Chinese startup DeepSeek’s cheaper AI is sharpening...
LONDON (Reuters) – Bitcoin fell below $100,000 on Monday, hitting its lowest in 11 days,...
PARIS (Reuters) -The United States has reported its first outbreak of H5N9 bird flu in...
(Reuters) -The cyberattack at UnitedHealth Group’s tech unit last year affected the personal information of...
By Nandita Bose and Kanishka Singh LAS VEGAS (Reuters) – President Donald Trump said on...
(Reuters) -U.S. President Donald Trump’s suggestion that Jordan and Egypt should take more Palestinians from...
By Luciana Magalhaes SAO PAULO (Reuters) – Brazil’s Ministry of Foreign Affairs plans to seek...
By Nupur Anand, Saeed Azhar and Pete Schroeder NEW YORK (Reuters) -Bank of America and...
By Emma-Victoria Farr FRANKFURT (Reuters) – Elon Musk made a surprise appearance during Germany’s AfD...